Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

7.67
Delayed Data
As of Aug 28
 -0.16 / -2.04%
Today’s Change
4.26
Today|||52-Week Range
11.15
+1.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues41.7M-571.0K248.0K1.9M
 
 
 
 
 
Cost of Goods Sold329.0K27.0K--178.0K
 
 
 
 
Depreciation And Amortization142.0K126.0K132.0K129.0K
 
 
 
 
 
 
Operating ExpensesGross Income41.2M-724.0K--1.6M
 
 
 
 
General Expenses10.6M10.0M10.1M12.5M
 
 
 
 
 
Research And Development6.7M6.2M6.5M6.5M
 
 
 
 
 
Total Operating Expenses11.1M10.2M10.2M12.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income30.6M-10.8M-10.0M-10.9M
 
 
 
 
 
Extraordinary Credit7.3M--0.000.00
 
 
Extraordinary Charge-1.1M-2.2M-300.0K-800.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income36.7M-12.9M-10.3M-11.7M
 
 
 
 
 
Income Taxes-227.0K-761.0K0.000.00
 
 
 
Net Income37.0M-12.2M-10.3M-11.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS69.6M69.6M69.6M69.6M
 
 
 
 
 
Shares To Calculate EPS Diluted72.9M69.6M69.6M69.6M
 
 
 
 
 
 
Earnings Per ShareEPS$0.51-$0.18-$0.15-$0.17
 
 
 
 
 
EPS Diluted$0.51-$0.18-$0.15-$0.17